Correlation Between Biotage AB and CellaVision

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotage AB and CellaVision at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotage AB and CellaVision into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotage AB and CellaVision AB, you can compare the effects of market volatilities on Biotage AB and CellaVision and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotage AB with a short position of CellaVision. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotage AB and CellaVision.

Diversification Opportunities for Biotage AB and CellaVision

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Biotage and CellaVision is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Biotage AB and CellaVision AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CellaVision AB and Biotage AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotage AB are associated (or correlated) with CellaVision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CellaVision AB has no effect on the direction of Biotage AB i.e., Biotage AB and CellaVision go up and down completely randomly.

Pair Corralation between Biotage AB and CellaVision

Assuming the 90 days trading horizon Biotage AB is expected to under-perform the CellaVision. In addition to that, Biotage AB is 1.65 times more volatile than CellaVision AB. It trades about -0.28 of its total potential returns per unit of risk. CellaVision AB is currently generating about 0.1 per unit of volatility. If you would invest  22,100  in CellaVision AB on October 23, 2024 and sell it today you would earn a total of  650.00  from holding CellaVision AB or generate 2.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Biotage AB  vs.  CellaVision AB

 Performance 
       Timeline  
Biotage AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotage AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
CellaVision AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CellaVision AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Biotage AB and CellaVision Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotage AB and CellaVision

The main advantage of trading using opposite Biotage AB and CellaVision positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotage AB position performs unexpectedly, CellaVision can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CellaVision will offset losses from the drop in CellaVision's long position.
The idea behind Biotage AB and CellaVision AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope